GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Medicilon Inc (SHSE:688202) » Definitions » EV-to-FCF

Shanghai Medicilon (SHSE:688202) EV-to-FCF : -32.36 (As of Dec. 15, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Shanghai Medicilon EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Shanghai Medicilon's Enterprise Value is ¥4,472.8 Mil. Shanghai Medicilon's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was ¥-138.2 Mil. Therefore, Shanghai Medicilon's EV-to-FCF for today is -32.36.

The historical rank and industry rank for Shanghai Medicilon's EV-to-FCF or its related term are showing as below:

SHSE:688202' s EV-to-FCF Range Over the Past 10 Years
Min: -19515.15   Med: -26.72   Max: 4932.03
Current: -34.58

During the past 10 years, the highest EV-to-FCF of Shanghai Medicilon was 4932.03. The lowest was -19515.15. And the median was -26.72.

SHSE:688202's EV-to-FCF is ranked worse than
100% of 392 companies
in the Biotechnology industry
Industry Median: 8.19 vs SHSE:688202: -34.58

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2024-12-15), Shanghai Medicilon's stock price is ¥35.95. Shanghai Medicilon's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was ¥-2.150. Therefore, Shanghai Medicilon's PE Ratio (TTM) for today is At Loss.


Shanghai Medicilon EV-to-FCF Historical Data

The historical data trend for Shanghai Medicilon's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Medicilon EV-to-FCF Chart

Shanghai Medicilon Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -76.48 104.94 185.22 -43.94 -56.46

Shanghai Medicilon Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -33.88 -56.46 -30.19 -23.93 -32.39

Competitive Comparison of Shanghai Medicilon's EV-to-FCF

For the Biotechnology subindustry, Shanghai Medicilon's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Medicilon's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shanghai Medicilon's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Shanghai Medicilon's EV-to-FCF falls into.



Shanghai Medicilon EV-to-FCF Calculation

Shanghai Medicilon's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=4472.843/-138.228
=-32.36

Shanghai Medicilon's current Enterprise Value is ¥4,472.8 Mil.
Shanghai Medicilon's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-138.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Medicilon  (SHSE:688202) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Shanghai Medicilon's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=35.95/-2.150
=At Loss

Shanghai Medicilon's share price for today is ¥35.95.
Shanghai Medicilon's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-2.150.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Shanghai Medicilon EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Shanghai Medicilon's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Medicilon Business Description

Traded in Other Exchanges
N/A
Address
Lane 67, Libing Road, Building 5, Pilot Free Trade Zone, Shanghai, CHN, 201299
Shanghai Medicilon Inc is a comprehensive biomedical research and developemnt service company. It provides a full range of one-stop new drug development services for pharmaceutical companies and research institutions around the world in line with domestic and international reporting standards.
Executives
Chen Jin Zhang Director
Chen Guo Xing Director
Lin Zhang Qing Director
Peng Shuang Qing Core technical personnel
Li Zhi Gang Core technical personnel
Xu Yong Mei Core technical personnel
Liu Bin Bin senior management
Zhang Xiao Dong senior management
Xue Chao senior management
Ma Xing Quan senior management
Directors, senior managers, core technical personn
Cai Jin Na Directors, senior managers

Shanghai Medicilon Headlines

No Headlines